Response to Bridging Therapy as a Prognostic Indicator of Post-Transplantation Hepatocellular Carcinoma Recurrence and Survival: A Systematic Review
Paweł Topolewski, Dariusz Łaski, Martyna Łukasiewicz, Piotr Domagała, Roeland F de Wilde, Wojciech G Polak, Maen Abdelrahim · 2024
Read Response to Bridging Therapy as a Prognostic Indicator of Post-Transplantation Hepatocellular Carcinoma Recurrence and Survival: A Systematic Review by Paweł Topolewski, Dariusz Łaski, Martyna Łukasiewicz, Piotr Domagała, Roeland F de Wilde, Wojciech G Polak, Maen Abdelrahim (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11592521.txt.
Description
Paweł Topolewski and co-authors review whether a liver cancer patient's response to pre-transplant treatment predicts how they fare after a liver transplant, in a 2024 systematic review. Bridging therapy treats the tumor while the patient waits for a donor organ. Whether response to it forecasts recurrence and survival was unsettled.
Searching two databases under standard review rules, the team found five studies. Four carried a serious risk of bias and one a moderate risk, which tempers the findings. Patients whose scans showed a complete or partial response tended to do best after transplant. Poor response or growth during bridging went with worse survival. Data were too thin to judge tissue-based response. The authors urge future transplant scoring models to fold in scan, tissue, and molecular features of the tumor.
Catalog record
| CREATOR | Paweł Topolewski, Dariusz Łaski, Martyna Łukasiewicz, Piotr Domagała, Roeland F de Wilde, Wojciech G Polak, Maen Abdelrahim |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |